Effect of tadalafil in chronic renal failure rabbits:relevance to erectile dysfunction

被引:0
|
作者
Mengyuan ZHANGQiang FUWei BIAN Department of UrologyProvincial Hospital Affiliated to Shandong UniversityJinan China [250021 ]
机构
关键词
D O I
暂无
中图分类号
R692.5 [肾功能衰竭];
学科分类号
摘要
It is of great importance to investigate an effective and reliable medication against chronic renal failure (CRF)-related erectile dysfunction (ED),which aims to improve patients' life qualities.The concentrations of cyclic guanosine monophosphate (cGMP) in the corpus cavernosal smooth muscle of both CRF and control rabbits were measured.The effects of various concentrations of tadalafil,papaverine,and sodium nitroprusside on the relaxation responses of corpus cavernosal smooth muscle pre-contracted with phenylephrine in CRF rabbits were observed.There was significant difference in the concentration of cGMP between CRF and control rabbits (P<0.01).Tadalafil had the greatest impacts on CRF rabbits when given the same concentration of papaverine or sodium nitroprusside and particularly significant differences were identified under the concentration levels of 10-5 and 10-4 mol/L (P<0.01).The results suggest that the cGMP concentrations of the corpus cavernosum had been greatly reduced in CRF rabbits compared with control rabbits and that tadalafil may be an ideal medication for use in the treatment of CRF-related ED.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 50 条
  • [31] Tadalafil population pharmacokinetics in patients with erectile dysfunction
    Iñaki F. Trocóniz
    Christiane Tillmann
    Alexander Staab
    Javier Rapado
    S. Thomas Forgue
    European Journal of Clinical Pharmacology, 2007, 63 : 583 - 590
  • [32] Tadalafil preferred to sildenafil as treatment for erectile dysfunction
    Jim Casey
    Nature Clinical Practice Urology, 2006, 3 (2): : 68 - 68
  • [33] Tadalafil therapy for erectile dysfunction following prostatectomy
    Kadioglu, Ates
    Ortac, Mazhar
    Dincer, Murat
    Brock, Gerald
    THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (03) : 146 - 151
  • [34] Effects of tadalafil on erectile dysfunction in men with diabetes
    de Tejada, IS
    Anglin, G
    Knight, JR
    Emmick, JT
    DIABETES CARE, 2002, 25 (12) : 2159 - 2164
  • [35] Tadalafil population pharmacokinetics in patients with erectile dysfunction
    Troconiz, Inaki F.
    Tillmann, Christiane
    Staab, Alexander
    Rapado, Javier
    Forgue, S. Thomas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) : 583 - 590
  • [36] EFFICACY OF TADALAFIL FOR TREATING CHRONIC PROSTATITIS/ CHRONIC PELVIC PAIN SYNDROME IN PATIENTS WITHOUT ERECTILE DYSFUNCTION
    Park, Hyun Jun
    Park, Sung Woo
    Park, Nam Cheol
    JOURNAL OF UROLOGY, 2019, 201 (04): : E779 - E780
  • [37] The potential effect of ambrisentan as monotherapy and combined with tadalafil on diabetic erectile dysfunction in rats
    Nabeh, Omnia Azmy
    El-Batrawy, Fatma Ahmed
    Khorshid, Omayma Anwar
    Soliman, Ghada Farouk
    UROLOGIA JOURNAL, 2024, 91 (01) : 159 - 169
  • [38] The effect of cardiovascular morbidity on clinical response provided by tadalafil in patients with erectile dysfunction
    Selvi, Ismail
    Baydilli, Numan
    Akinsal, Emre Can
    ANDROLOGIA, 2021, 53 (02)
  • [39] Comparison Of Efficacy And Safety Of "On Demand" Tadalafil And Daily Tadalafil For The Treatment Of Erectile Dysfunction
    McMahon, C. G.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 48 - 49
  • [40] Erectile dysfunction in renal failure patients and renal transplant recipients.
    Benoît, G
    PROGRES EN UROLOGIE, 2005, 15 (03): : 455 - 456